Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors. 2002

Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester Cancer Center, 575 Elmwood Avenue, Rochester, NY 14642, USA.

BACKGROUND Human kallikrein 2 (hK2) and prostate-specific antigen (PSA) are serine proteases in the human kallikrein gene family that are 80% identical at the protein level. Like PSA, hK2 is expressed primarily in the prostate, making it an attractive bio-marker for prostate cancer development. In addition, its potent enzymatic activity may functionally affect the biology of prostate cancer. In order to further elucidate the possible roles of hK2 in prostate cancer, we have generated a panel of hK2-specific, non-PSA cross-reactive monoclonal antibodies. METHODS A novel tumor-immunization strategy was used to produce monoclonal antibodies. Human hK2 cDNA was transfected into a BALB/c tumor cell line and used to immunize both BALB/c and PSA-expressing BALB/c.PSA transgenic mice. Because the BALB/c.PSA transgenic mouse showed a biased response towards hK2, a B cell fusion was performed using spleen cells from a transgenic mouse immunized in this fashion. RESULTS A panel of monoclonal antibodies was produced and shown to be hK2-specific using newly developed hK2-specific sandwich ELISA and ELIspot assays. One of the monoclonal antibodies (6B7) was used to detect hK2 in human prostate by immunohistochemistry. Interestingly, two of the antibodies affected the function of hK2. The 1F8 antibody enhanced the enzymatic activity of hK2 whereas the 3C7 antibody inhibited its function. CONCLUSIONS These hK2-specific antibodies illustrate a novel approach for constructing B-cell hybridomas and provide useful reagents to examine the role of hK2 in the biology and detection of prostate cancer.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
May 1998, Urology,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
April 1995, Molecular and cellular endocrinology,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
February 2020, Monoclonal antibodies in immunodiagnosis and immunotherapy,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
April 1999, Urology,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
May 1997, The Prostate,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
January 1996, The Prostate. Supplement,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
April 2007, Hybridoma (2005),
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
January 1999, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
October 2010, PloS one,
Terrence L Fisher, and MaryAnn Nocera, and Richard A Willis, and Michael J Turner, and C Siddiq Abdul Alim, and Deborah M Brown, and Patricia A Bourne, and P Anthony di Sant'Agnese, and Edward M Messing, and Edith M Lord, and John G Frelinger
December 2016, Monoclonal antibodies in immunodiagnosis and immunotherapy,
Copied contents to your clipboard!